SHEDDING CONFIRMED: mRNA-generated covid spike proteins

New Post Public Reply Private Reply Replies (0) Message Board
Rusty
320
SHEDDING CONFIRMED: mRNA-generated covid spike proteins found in skin lesions MONTHS after vaccination

Japanese doctors have reported that mRNA-induced spike proteins from Covid-19 “vaccines” do persist in the body for at least several months post-injection.

Contradicting government and media claims that jab spike proteins dissipate almost immediately, the discovery was made on a 64-year-old person who developed persistent and painful skin lesions just days after receiving the messenger RNA shot.


Upon analysis, it was discovered that the patient had developed the varicella-zoster virus, which causes chickenpox. He was treated with one gram daily of valacyclovir, a drug commonly used to treat herpes viruses.

When this was largely ineffective, doctors raised the man’s dosage of valacyclovir to three grams per day, which ultimately got rid of the lesions.

Doctors then decided to test the lesions for evidence of spike proteins because the patient had become gravely ill almost immediately following injection. They discovered that spike proteins were still present many months after the patient was shot.

“Immunostaining with anti-coronavirus spike protein (SP) antibody revealed the SP expression in the intravesicular cells in the epidermis and endothelial cells of the inflamed vessels in the dermis,” they wrote about their findings.

“In addition, the SP was also found in the endothelial cells of venules in the subcutaneous fat tissue underlying the herpetic vasculitis lesion.”

NATURE study confirms: Triple-vaccinated developing clots associated with “long covid”

Did Pfizer and Moderna create ZOMBIE injections that simply do not die?

In speculating about the discovery, reporter Alex Berenson wrote that the chemical modifications made by both Pfizer and Moderna with their mRNA mystery shots appear to induce the constant production spike proteins.

He says the two drug companies “may have produced a zombie vaccine that will not die,” though the researchers themselves put it like this:

“A plausible hypothesis was that the stabilization of RNA by substituting methyl-pseudouridine for all the uridine nucleotides for BNT162b2 might result in long-time production of the encoded SP from any cells.”

In other words, whatever those covid so-called “vaccines” contain encodes the constant and potentially unending production of deadly spike proteins inside the body.

This is further substantiated by the fact that many fully jabbed patients are now suffering from autoimmune crisis such as the unexpected development of Type 1 diabetes, which is normally identified and diagnosed in early childhood.

Keep in mind that the U.S. Centers for Disease Control and Prevention (CDC) recently and quietly removed information from its website about mRNA spike proteins. Before, the CDC claimed that mRNA spike proteins go away not long after injection. Now, the CDC is silent about the matter.

Reuters also falsely claimed for quite some time that there is “no proof” that spike proteins “created in response to mRNA vaccines are harmful to the body.” Now we know for a fact that this is untrue.

“Physicians cannot find what they won’t seek – and sought what wasn’t there for two years,” wrote one of Berenson’s readers about how no stateside doctors would ever dare to investigate post-injection lesions for the presence of spike proteins – even though these same doctors bought right into the plandemic fearmongering for a “virus” that has never even been proven to exist.

“Going on 16 months of skin lesions bleeding under the skin of my left knee for no apparent reason,” wrote another who says she got the shots. “All labs normal – maybe this is what’s going on? Great!

Vaccines are the gift that keep on giving (and not in a good way).”

Another thanked the Lord that she just said no to the vax, adding that no matter what, “I’m never going to get it.”

The latest Fauci Flu shot news can be found at Immunization.news.

https://dcdirtylaundry.com/shedding-confirmed...ccination/



Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 235

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 347

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Adding Fireplaces: Home Comfort or Construction Headache?

Updated Category News Views 276

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 183

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 238

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 522

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 271

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 451

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 202

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 104

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

Canadian Stocks Surge: Understanding Market Dynamics and Trends

Updated Category News Views 178

Canadian Stocks See Notable Gains The Canadian stock market has shown encouraging signs of growth lately, with various sectors playing a part in this upward movement. The S&P/TSX Composite Index achieved a remarkable increase of 0.57%, marking a significant point in its trading history. Key Sectors Driving Market Growth The rise in stock prices can largely be credited to...

Continue Reading
Bookmark Medical Enters Michigan Via Village Medical Buy

Updated Category News Views 38

Stepping into Michigan It might not be a Wall Street headliner, but Bookmark Medical's move into Michigan sure says a lot about their growth ambitions. On August 3, 2026, the Nashville-based healthcare group wrapped up acquiring Village Medical Michigan. This is Bookmark's maiden voyage into the Great Lake State, where it's taken over the reins of seven primary care...

Continue Reading
Astrotech Corporation Reports Impressive Year-End Results

Updated Category News Views 134

Astrotech Corporation Reports Strong Fiscal Performance Recently, Astrotech Corporation (NASDAQ: ASTC) announced its financial results for the fiscal year that ended on June 30. The report highlights notable advancements from its subsidiary, 1st Detect, and how these developments are contributing to overall revenue and growth potential. Key Financial Highlights The...

Continue Reading
Neptune Flood Research Highlights Path to Private Insurance Transition

Updated Category News Views 165

Neptune Flood Research Report Offers Insights on NFIP Transition Recent research indicates that private flood insurers may be capable of taking on 95% of policies from the NFIP, helping to mitigate federal financial exposure. Neptune Flood Research Group has published a comprehensive report analyzing the U.S. flood insurance market. The study emphasizes the challenges...

Continue Reading
Valerio Therapeutics Shifts Focus to Early-Stage Drug Development

Updated Category News Views 131

Valerio Therapeutics Announces Strategic Refocus Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO) has made a pivotal announcement regarding its strategic business direction. The company has decided to halt all clinical trials, including the ongoing VIO-01 trial. This decision comes in response to significant financing challenges impacting the organization. While...

Continue Reading